Canadian journal of diabetes最新文献

{"title":"Letter to the Editor: Cannabis Hyperemesis Syndrome Can Mimic Diabetic Gastroparesis in Cannabis Users with Type 1 Diabetes.","authors":"Syeda Kashaf Batool, Fatima Asif, Muhammad Owais","doi":"10.1016/j.jcjd.2025.05.004","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.05.004","url":null,"abstract":"","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144153133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Beyond Glucose Control: A Critical Appraisal of Virtual vs. In-Person Care for Gestational Diabetes\".","authors":"Muhammad Khubaib Iftikhar","doi":"10.1016/j.jcjd.2025.05.006","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.05.006","url":null,"abstract":"<p><p>the article by Dolatabadi et al. offers timely insights into the use of virtual care in managing gestational diabetes mellitus (GDM), but several critical limitations temper the strength and applicability of its conclusions. This Letter to the Editor outlines concerns regarding the study's retrospective design, its omission of patient-reported and adherence-related outcomes, and its limited generalizability. Drawing on recent literature, including evaluations aligned with the Quadruple Aim and meta-analyses of digital interventions, we argue for more robust and patient-centered methodologies in future research. Virtual care in GDM holds promise, but its real-world effectiveness must be assessed through rigorous, equitable, and multidimensional frameworks.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144153131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Describing the experiences of healthcare providers who supported an outreach program to deliver point-of-care screening in adults with Type 1 and Type 2 diabetes who are experiencing homelessness in Calgary, Canada: A qualitative analysis.","authors":"Hannah M Yaphe, Sara Scott, Huanghe Ding, Breanna McSweeney, Eshleen Grewal, David Jt Campbell","doi":"10.1016/j.jcjd.2025.05.002","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.05.002","url":null,"abstract":"<p><strong>Objectives: </strong>Unstable housing and homelessness are associated with increased risks of diabetes-related morbidity and mortality. Concordantly, as few as 12-30% of people with lived experience of homelessness (PWLEH) complete recommended screening for microvascular complications of diabetes. Innovative models of care delivery are needed to address this disparity. We recently piloted a novel, community-based, point-of-care screening program for diabetes complications (the SAFER model of care, i.e. Screening for glycosylated hemoglobin (A1c), feet, eyes and renal function) in Calgary, Alberta. Herein, we describe the experiences of providers who supported the implementation of SAFER to explore factors which influenced the adoption and maintenance of this innovative model.</p><p><strong>Methods: </strong>Complete details of the intervention are reported elsewhere. Semi-structured interviews were conducted with service providers and clinic managers at the sites which hosted the SAFER intervention. Transcribed data were analyzed through qualitative thematic analysis with NVivo software.</p><p><strong>Results: </strong>Nine participants from two organizations were interviewed. Participants described four thematic messages regarding their experiences: 1) The intervention successfully addressed relevant barriers to enable clients to complete screening, 2) Generating and maintaining client engagement requires dedicated effort, 3) Competing priorities for providers and organizations can be a barrier to sustaining programs - even when effective, 4) Programs introduced through research studies are inherently dependent upon resources that are time-limited in nature which impacts the ability to maintain the program long-term.</p><p><strong>Conclusion: </strong>Lessons learned from providers' experiences with SAFER can inform the planning and delivery of other programs like SAFER to address ongoing disparities in diabetes care for PWLEH.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to \"Virtual vs. In-Person Care in Gestational Diabetes Management: A Retrospective Cohort Analysis\".","authors":"Rongrong Chen, Lin Sheng, Xiaohan Zhang","doi":"10.1016/j.jcjd.2025.05.001","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.05.001","url":null,"abstract":"","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144121656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Letter To Editor: Temporal trends in the rates of foot complications and lower extremity amputation related to type 1 and 2 diabetes in adults in selected Canadian provinces\".","authors":"Noor Ul Huda, Muhammad Raza, Maryam Maheen","doi":"10.1016/j.jcjd.2025.04.007","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.04.007","url":null,"abstract":"","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144058121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insomnia and Cardiometabolic Health: Bridging the Sleep Deficit to Disease Prevention.","authors":"J W Kim, A B Jain, A Khullar","doi":"10.1016/j.jcjd.2025.04.008","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.04.008","url":null,"abstract":"<p><p>Insomnia a condition marked by difficulty initiating or maintaining sleep, or early morning awakenings despite an adequate opportunity for adequate rest. It affects up to one-third of adults, with around 10% meeting the criteria for insomnia disorder. Emerging research increasingly points to insomnia as a significant, modifiable risk factor for cardiometabolic diseases, including type 2 diabetes, cardiovascular disease, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease (MASLD). This narrative review synthesizes the latest evidence linking insomnia to heightened cardiometabolic risk, especially type 2 diabetes. Additionally, we discuss how sleep deprivation influences metabolic processes and cardiovascular health, emphasizing the association between insomnia and cardiometabolic disease. Despite its prevalence and clear impact on health, insomnia remains trivialized, underdiagnosed and inadequately managed. Only a minority of individuals seek medical advice for sleep disturbances, highlighting an urgent need for improved screening and management, particularly for those with cardiometabolic conditions. This review aims to provide healthcare professionals with practical recommendations for identifying and managing insomnia, a underrecognized way to ultimately reduce the burden of cardiometabolic diseases. Integrating sleep health into cardiometabolic care will represent a significant step forward in reducing the global burden of chronic cardiometabolic diseases.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Virtual vs. In-Person Care in Gestational Diabetes Management: A Retrospective Cohort Analysis.","authors":"Samin Dolatabadi, Jennifer M Yamamoto, Erin A Brennand, Lois E Donovan, Jamie L Benham","doi":"10.1016/j.jcjd.2025.04.002","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.04.002","url":null,"abstract":"<p><strong>Objectives: </strong>The rising prevalence of gestational diabetes (GDM) presents a challenge to healthcare systems. Virtual care has emerged as a potential solution to alleviate this burden, but limited data exist on its effectiveness. This study evaluated maternal and neonatal outcomes in individuals with GDM managed with virtual care versus in-person care.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted among individuals with GDM attending interdisciplinary diabetes in pregnancy clinics in Calgary, Alberta between 2017-2022. The primary exposure was modality of the initial visit (virtual or in-person) with a diabetes educator. Logistic regression models were used to analyze the relationship between visit modality and outcomes, adjusting for multiples, socioeconomic status, maternal age, infant sex, parity, and before vs during the SARS-CoV-2 coronavirus (COVID-19) pandemic.</p><p><strong>Results: </strong>Of the 9,511 individuals included, 4,236 had an initial virtual visit. Those in the virtual care group had lower odds of delivering large-for-gestational-age infants (aOR 0.79, 95% CI 0.65-0.97) and undergoing caesarean section (aOR 0.88, 95% CI 0.79-0.99). They also had lower odds of missing at least one appointment (aOR 0.89, 95% CI 0.77-0.99) and greater odds of being prescribed both insulin and metformin (aOR 1.30, 95% CI 1.16-1.46). No significant differences were found in rates of operative vaginal birth, induction of labour, small for gestational age infants, 5-minute Apgar score <7, or neonatal intensive care unit admission.</p><p><strong>Conclusion: </strong>This study highlights the potential of virtual care to enhance GDM management. Further research is needed to assess its broader impact and optimize implementation strategies for diverse populations.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Retrospective Analysis of Postpartum Glucose Testing Incidence by Prenatal Care Provider Specialty in a Canadian Gestational Diabetes Cohort.","authors":"Kathleen Baker, Nikki Stephenson, Colleen Cuthbert, Doreen Rabi, Amy Metcalfe","doi":"10.1016/j.jcjd.2025.03.006","DOIUrl":"10.1016/j.jcjd.2025.03.006","url":null,"abstract":"<p><strong>Objectives: </strong>Gestational diabetes mellitus (GDM) increases future risks of type 2 diabetes and cardiovascular disease. Despite Diabetes Canada guidelines recommending postpartum glucose testing after GDM, uptake remains low. Canadian population-based studies are needed to examine system-level factors affecting uptake.</p><p><strong>Methods: </strong>We used linked Alberta Health data sets, including births from 2017 to 2018, to identify prenatal care provider specialty (general practitioner [GP], obstetrician [OB], or midwife [RM]), postpartum glucose tests, and cohort demographics. Outcomes were: 1) gold standard testing, which is oral glucose tolerance testing (OGTT) within 6 weeks to 6 months postpartum; and 2) any glucose test within 6 weeks to 1 year. We used adjusted logistic regression modelling to estimate the association between test incidence and provider specialty.</p><p><strong>Results: </strong>From 105,691 births we identified a cohort of 9,884 with GDM. Uptake of postpartum glucose testing was low: 22.2% (95% confidence interval [CI] 21.4% to 23.1%) received gold standard testing and 53.9% (95% CI 52.9% to 54.9%) received any glucose test. When compared with the OB group, GP patients were less likely to receive both glucose test outcomes (odds ratio [OR]_GS=0.86, 95% CI 0.77 to 0.95; OR_Any=0.88, 95% CI 0.81 to 0.96). Patients of RMs were also less likely to receive both glucose test outcomes (OR_GS=0.67, 95% CI 0.46 to 0.96; OR_Any=0.88, 95% CI 0.67 to 1.15).</p><p><strong>Conclusions: </strong>We report low postpartum glucose testing overall and found no clinically meaningful differences across provider specialties. The higher incidence of any glucose testing suggests that providers may be prioritizing alternative tests over the OGTT protocol for GDM patients.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144055495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between circulating vitamin C concentrations and risk of diabetes mellitus: dual evidence from NHANES database and Mendelian randomization analysis.","authors":"Zhitong Li, Jinchang Liu, Xingyu Li, Shiwei Liu","doi":"10.1016/j.jcjd.2025.04.001","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.04.001","url":null,"abstract":"<p><p>This study explores the link between circulating vitamin C levels and the risk of diabetes mellitus (DM) using data from the National Health and Nutrition Examination Survey (NHANES) for the cycles of 2003-2004, 2005-2006, and 2017-2018. Our analysis revealed a significant inverse relationship, showing that higher levels of vitamin C are associated with a reduced risk of DM. Specifically, higher vitamin C concentrations correlated with lower odds of DM, particularly at elevated quartile levels. Despite these findings, Mendelian randomization (MR) analysis did not establish a causal link between vitamin C and type 1 diabetes (T1DM). Additionally, previous MR studies found no causal relationship between vitamin C and type 2 diabetes (T2DM). These results suggest that while vitamin C levels are inversely associated with DM risk, this association may not be causal. Potential confounding factors or reverse causation could explain the observed relationship. The complexity of these interactions emphasizes the need for further research to clarify the biological mechanisms and assess how lifestyle or other metabolic factors might influence the relationship between vitamin C and diabetes.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144059731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Uptake and Factors Associated with COVID-19 Vaccination Among 3,779,733 Adults Living With and Without Diabetes: A Population Cohort Study in a Universal Health Care Setting.","authors":"Sonia Butalia, Ronald J Sigal, Baiju R Shah, Jamie L Benham, Brandy Wicklow, Catherine H Yu, Kaberi Dasgupta, Luan M Chu, Shazhan Amed, Cora Constantinescu, Padma Kaul","doi":"10.1016/j.jcjd.2025.03.008","DOIUrl":"https://doi.org/10.1016/j.jcjd.2025.03.008","url":null,"abstract":"<p><strong>Objective: </strong>People with diabetes are vulnerable to health inequities and population level COVID-19 vaccine uptake among adults with diabetes is unknown. Our aim was to assess COVID-19 vaccine uptake among adults with and without diabetes and the factors associated with vaccination.</p><p><strong>Methods: </strong>This retrospective, population-based cohort study included all adults living in Alberta, Canada on December 14, 2020, the date COVID-19 vaccines became available. Individual diabetes status was determined between April 1, 2002, and December 14, 2020, using a validated algorithm. Individuals were followed until March 31, 2022. The primary outcome was full vaccination as defined by the manufacturer. Descriptive statistics were used to compare vaccination status among people with and without diabetes. Unadjusted and multivariable-adjusted Cox proportional hazards models were applied to assess factors associated with full vaccination uptake.</p><p><strong>Results: </strong>Among 3,779,733 adults (49.7% female, mean age 45.1 ± 17.3 years), 9.8% had diabetes. A higher proportion of people with diabetes, compared to those without, were fully vaccinated (83.9% vs. 74.6%, p<0.001; males aHR 1.34, 95% CI 1.33-1.35; females aHR 1.23, 95% CI 1.22-1.24). In people with diabetes, age over 65 years and statin use were associated with full vaccination, whereas lower socioeconomic status, rural residence, higher number of comorbidities, higher A1C, and insulin use were associated with lower vaccination uptake.</p><p><strong>Conclusions: </strong>People with diabetes had high COVID-19 vaccination uptake. Further work is needed to better understand the system and individual based facilitators of and barriers to, vaccine uptake, to inform future public health vaccine-based interventions.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}